Want to see BBIO full AI Analyst Report?
BridgeBio Pharma (BBIO) Revenue
BridgeBio Pharma Revenue
BridgeBio Pharma had a revenue of 353.17M in the quarter ending Sep 30, 2026, with 44.93%. This bring the company's revenue in the last twelve months to 945.54M, Increased 32.60%. In the fiscal year ending Dec 31, 2025, BridgeBio Pharma had annual revenue of 502.08M with 126.26% growth.
- Revenue (ttm)
- 945.54M
- Revenue Growth
- 167.27%
- P/S Ratio
- 29.08
- Revenue/Employee
- $598,424
- Employees
- 839
- Market Cap
- $14.60B
Revenue Chart
BridgeBio Pharma Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 502.08M | 280.18M | 126.26% |
| Dec 31, 2024 | 221.90M | 212.60M | 2285.27% |
| Dec 31, 2023 | 9.30M | -68.34M | -88.02% |
| Dec 31, 2022 | 77.65M | 7.93M | 11.38% |
| Dec 31, 2021 | 69.72M | 61.47M | 745.14% |
| Dec 31, 2020 | 8.25M | -32.31M | -79.66% |
| Dec 31, 2019 | 40.56M | 40.56M | ― |
| Dec 31, 2018 | 0.00 | 0.00 | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.